French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...
Morningstar4h
SAS' Overseas Expansion in the US and Italy Backed by Solid Demand and Generous Subsidies
All but Transphorm are listed in Taiwan and only makes up roughly 10% of SAS’ market capitalization in aggregate. Among the five, only AWSC has some semblance of an intangible asset moat source based ...